ArticleEuropean journal of nuclear medicine and molecular imaging2022

Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenib.

Osman Öcal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.